Thus, it is possible that systemic ALT-803 therapy may result in a broader activation of CD8+ T and NK cells as well as NKT cells compared to intravesical ALT-803, which could translate into a greater potential to effectively eradicate extravesical tumor (i.e., metastatic disease to lymph node or distant tissues). This evidence concerns the gene GPT and metastatic neoplasm.